BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS. Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model. Exp Neurol 2013;243:57-66. [PMID: 23353924 DOI: 10.1016/j.expneurol.2013.01.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Requejo C, López-de-Ipiña K, Ruiz-Ortega JÁ, Fernández E, Calvo PM, Morera-Herreras T, Miguelez C, Cardona-Grifoll L, Cepeda H, Ugedo L, Lafuente JV. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers. Front Neurosci 2020;14:590029. [PMID: 33154717 DOI: 10.3389/fnins.2020.590029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fagotti J, Targa ADS, Rodrigues LS, Noseda ACD, Dorieux FWC, Scarante FF, Ilkiw JL, Louzada FM, Chowdhury NR, van der Veen DR, Middleton B, Pennings JLA, Swann JR, Skene DJ, Lima MMS. Chronic sleep restriction in the rotenone Parkinson's disease model in rats reveals peripheral early-phase biomarkers. Sci Rep 2019;9:1898. [PMID: 30760786 DOI: 10.1038/s41598-018-37657-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bassani TB, Gradowski RW, Zaminelli T, Barbiero JK, Santiago RM, Boschen SL, da Cunha C, Lima MM, Andreatini R, Vital MA. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats. Brain Res 2014;1593:95-105. [PMID: 25301688 DOI: 10.1016/j.brainres.2014.09.068] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
4 Farajnia S, Meijer JH, Michel S. Age-related changes in large-conductance calcium-activated potassium channels in mammalian circadian clock neurons. Neurobiol Aging 2015;36:2176-83. [PMID: 25735218 DOI: 10.1016/j.neurobiolaging.2014.12.040] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
5 Kinoshita C, Aoyama K, Matsumura N, Kikuchi-Utsumi K, Watabe M, Nakaki T. Rhythmic oscillations of the microRNA miR-96-5p play a neuroprotective role by indirectly regulating glutathione levels. Nat Commun 2014;5:3823. [PMID: 24804999 DOI: 10.1038/ncomms4823] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
6 Camargo SMR, Vuille-dit-bille RN, Mariotta L, Ramadan T, Huggel K, Singer D, Götze O, Verrey F. The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease. J Pharmacol Exp Ther 2014;351:114-23. [DOI: 10.1124/jpet.114.216317] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
7 Rasmussen HE, Piazza BR, Forsyth CB, Keshavarzian A. Nutrition and Gastrointestinal Health as Modulators of Parkinson’s Disease. In: Folkerts G, Garssen J, editors. Pharma-Nutrition. Cham: Springer International Publishing; 2014. pp. 213-42. [DOI: 10.1007/978-3-319-06151-1_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
8 Sabbar M, Dkhissi-Benyahya O, Benazzouz A, Lakhdar-Ghazal N. Circadian Clock Protein Content and Daily Rhythm of Locomotor Activity Are Altered after Chronic Exposure to Lead in Rat. Front Behav Neurosci 2017;11:178. [PMID: 28970786 DOI: 10.3389/fnbeh.2017.00178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Snider KH, Sullivan KA, Obrietan K. Circadian Regulation of Hippocampal-Dependent Memory: Circuits, Synapses, and Molecular Mechanisms. Neural Plast 2018;2018:7292540. [PMID: 29593785 DOI: 10.1155/2018/7292540] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
10 Arnao V, Cinturino A, Mastrilli S, Buttà C, Maida C, Tuttolomondo A, Aridon P, D'Amelio M. Impaired circadian heart rate variability in Parkinson's disease: a time-domain analysis in ambulatory setting. BMC Neurol 2020;20:152. [PMID: 32326894 DOI: 10.1186/s12883-020-01722-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Cheng WY, Ho YS, Chang RC. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases. Ageing Res Rev 2022;78:101620. [PMID: 35405323 DOI: 10.1016/j.arr.2022.101620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Stewart J, Bachman G, Cooper C, Liu L, Ancoli-israel S, Alibiglou L. Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson’s disease. Exp Brain Res 2018;236:655-64. [DOI: 10.1007/s00221-017-5163-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Videnovic A, Willis GL. Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease? Mov Disord 2016;31:260-9. [PMID: 26826022 DOI: 10.1002/mds.26509] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
14 Musiek ES, Videnovic A. Sleep and clocks - implications for brain health. Neurobiol Sleep Circadian Rhythms 2017;2:1-3. [PMID: 31236492 DOI: 10.1016/j.nbscr.2016.12.001] [Reference Citation Analysis]
15 Lauretti E, Di Meco A, Merali S, Praticò D. Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson's disease. Mol Psychiatry 2017;22:280-6. [PMID: 27046648 DOI: 10.1038/mp.2016.47] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
16 Martino JK, Freelance CB, Willis GL. The effect of light exposure on insomnia and nocturnal movement in Parkinson's disease: an open label, retrospective, longitudinal study. Sleep Med 2018;44:24-31. [PMID: 29530365 DOI: 10.1016/j.sleep.2018.01.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Schroeder AM, Colwell CS. How to fix a broken clock. Trends Pharmacol Sci 2013;34:605-19. [PMID: 24120229 DOI: 10.1016/j.tips.2013.09.002] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 9.9] [Reference Citation Analysis]
18 Li H, Song S, Wang Y, Huang C, Zhang F, Liu J, Hong JS. Low-Grade Inflammation Aggravates Rotenone Neurotoxicity and Disrupts Circadian Clock Gene Expression in Rats. Neurotox Res 2019;35:421-31. [PMID: 30328585 DOI: 10.1007/s12640-018-9968-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Willis GL, Freelance CB. Emerging preclinical interest concerning the role of circadian function in Parkinson's disease. Brain Res 2018;1678:203-13. [PMID: 28958865 DOI: 10.1016/j.brainres.2017.09.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
20 Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K. Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men. Int J Epidemiol 2018;47:1679-86. [PMID: 29873737 DOI: 10.1093/ije/dyy098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
21 Gu Z, Wang B, Zhang YB, Ding H, Zhang Y, Yu J, Gu M, Chan P, Cai Y. Association of ARNTL and PER1 genes with Parkinson's disease: a case-control study of Han Chinese. Sci Rep 2015;5:15891. [PMID: 26507264 DOI: 10.1038/srep15891] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
22 Liu WW, Wei SZ, Huang GD, Liu LB, Gu C, Shen Y, Wang XH, Xia ST, Xie AM, Hu LF, Wang F, Liu CF. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson's disease mouse model. FASEB J 2020;34:6570-81. [PMID: 32246801 DOI: 10.1096/fj.201901565RR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Leng Y, Blackwell T, Cawthon PM, Ancoli-Israel S, Stone KL, Yaffe K. Association of Circadian Abnormalities in Older Adults With an Increased Risk of Developing Parkinson Disease. JAMA Neurol 2020;77:1270-8. [PMID: 32539075 DOI: 10.1001/jamaneurol.2020.1623] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 13.0] [Reference Citation Analysis]
24 Siwik CJ, Phillips K, Litvan I, Salmon P, Rodgers A, Jablonski M, Sephton SE. A Pilot Randomized Controlled Trial Investigating MBSR for Parkinson’s Disease Patients and Their Caregiving Partners: Effects on Distress, Social support, Cortisol, and Inflammation. Mindfulness. [DOI: 10.1007/s12671-022-01874-y] [Reference Citation Analysis]
25 Lou F, Li M, Luo X, Ren Y. CLOCK 3111T/C Variant Correlates with Motor Fluctuation and Sleep Disorders in Chinese Patients with Parkinson's Disease. Parkinsons Dis 2018;2018:4670380. [PMID: 29535854 DOI: 10.1155/2018/4670380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Oka H, Nakahara A, Umehara T. Rotigotine Improves Abnormal Circadian Rhythm of Blood Pressure in Parkinson's Disease. Eur Neurol 2018;79:281-6. [PMID: 29763930 DOI: 10.1159/000489574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Smolensky MH, Hermida RC, Reinberg A, Sackett-Lundeen L, Portaluppi F. Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention. Chronobiol Int 2016;33:1101-19. [PMID: 27308960 DOI: 10.1080/07420528.2016.1184678] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 16.3] [Reference Citation Analysis]
28 French IT, Muthusamy KA. A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures. Front Aging Neurosci 2016;8:114. [PMID: 27242523 DOI: 10.3389/fnagi.2016.00114] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
29 Ortuño-Lizarán I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N. Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease. Acta Neuropathol Commun 2018;6:90. [PMID: 30201049 DOI: 10.1186/s40478-018-0596-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
30 Verugina NI, Levin OS, Lyashenko EA. [Neuroendocrine and metabolic impairments in patients with Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:67-73. [PMID: 33205933 DOI: 10.17116/jnevro202012010267] [Reference Citation Analysis]
31 He G, Liu CF, Ye Q, Liu Z, Jin M, Shang H, Chen L, Tuo H, Jiang H, Cai J, Joshi K, Cooper J, Zi L, Chen S. Prevalence and profile of nocturnal disturbances in Chinese patients with advanced-stage Parkinson's disease: a cross-sectional epidemiology study. BMC Neurol 2021;21:194. [PMID: 33980158 DOI: 10.1186/s12883-021-02217-5] [Reference Citation Analysis]
32 dos Santos AB, Kohlmeier KA, Barreto GE. Are Sleep Disturbances Preclinical Markers of Parkinson’s Disease? Neurochem Res 2015;40:421-7. [DOI: 10.1007/s11064-014-1488-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
33 Julienne H, Buhl E, Leslie DS, Hodge JJL. Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes. Neurobiol Dis 2017;104:15-23. [PMID: 28435104 DOI: 10.1016/j.nbd.2017.04.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
34 Grieb B, von Nicolai C, Engler G, Sharott A, Papageorgiou I, Hamel W, Engel AK, Moll CK. Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease. Front Syst Neurosci 2013;7:95. [PMID: 24348346 DOI: 10.3389/fnsys.2013.00095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
35 Li L, Zhao Z, Ma J, Zheng J, Huang S, Hu S, Gu Q, Chen S. Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study. Front Neurosci. 2020;14:505. [PMID: 32508583 DOI: 10.3389/fnins.2020.00505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Kudo T, Loh DH, Tahara Y, Truong D, Hernández-Echeagaray E, Colwell CS. Circadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid. ASN Neuro 2014;6:e00133. [PMID: 24328694 DOI: 10.1042/AN20130042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
37 Videnovic A, Lazar AS, Barker RA, Overeem S. 'The clocks that time us'--circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 2014;10:683-93. [PMID: 25385339 DOI: 10.1038/nrneurol.2014.206] [Cited by in Crossref: 175] [Cited by in F6Publishing: 164] [Article Influence: 21.9] [Reference Citation Analysis]
38 Mantovani S, Smith SS, Gordon R, O'Sullivan JD. An overview of sleep and circadian dysfunction in Parkinson's disease. J Sleep Res 2018;27:e12673. [PMID: 29493044 DOI: 10.1111/jsr.12673] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
39 Videnovic A. Disturbances of Sleep and Alertness in Parkinson's Disease. Curr Neurol Neurosci Rep 2018;18:29. [PMID: 29675716 DOI: 10.1007/s11910-018-0838-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
40 De Pablo-fernández E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT. Neuroendocrine abnormalities in Parkinson's disease. J Neurol Neurosurg Psychiatry 2017;88:176-85. [DOI: 10.1136/jnnp-2016-314601] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]